The European Orthopedic Biomaterials market report covers and includes the Bone Graft Substitutes Market, Orthopedic Growth Factor Market , Orthopedic Cell Therapy Market, Hyaluronic Acid Viscosupplementation Market, and the Orthopedic Cartilage Repair Market.
Overall, the U.S. Orthopedic Biomaterials market was valued at $3.7 billion in 2021. This is expected to increase over the forecast period at a CAGR of 3.6% to reach $4.7 billion. Demographic factors in the U.S. continue to be the largest driver within the orthopedic biomaterials market. This is primarily due to the growing elderly
Industry Trends A particular trend in the U.S. orthobiologics market is competitors that are seeking to penetrate high growth segments outside their traditional space by distributing existing products manufactured by other companies, rather than creating their own. This often involves partnering with a company by taking on the costs associated with regulation and market approval,
Articular cartilage is a connective tissue that lines the ends of bones in joints. It provides shock absorption within the joint and prevents abrasion from occurring to the articular surfaces of bone. Cartilage, in its various forms, is found in intervertebral discs, as the articular lining for joint surfaces and in the meniscal pads of the knees. All types of this tissue are poorly vascularized and, as proper healing requires adequate blood flow, cartilage is one of the slowest healing tissues of the body. Osteoarthritis is cumulative trauma that eventually wears away at cartilaginous surfaces, exposing the underlying bone to additional wear. There are few alternatives to osteobiologic cartilage repair. Damage to cartilage is difficult to treat because the tissue lacks blood supply and has limited capacity for self repair.